Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

UNKNOWN

Blood Test for Ovarian Cancer Associated Antibodies (CAAb)

Lead Sponsor:

Lab Discoveries Ltd.

Conditions:

Ovarian Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

Blood is collected from patients and cultured in a CimTube (a test tube with stimulation media) for several days. Following the culture step, the supernatant fluid is tested for the presence of CAAb o...

Detailed Description

General Information Antibodies are a specific response to any "foreign" antigen, and they are usually detectable in the serum within 5-7 days after the initial exposure to it. However, there are some...

Eligibility Criteria

Inclusion

  • Ovarian cancer patients:
  • Subjects 18 years or over.
  • Patients suspected of ovarian cancer (including peritoneal carcinoma). The clinical suspicion will include one of the following: pelvic mass (by pelvic examination or other imaging techniques), or high cancer antigen (CA)-125 levels in post-menopausal women, ascites, or due to incidental finding of distant metastasis. Final analysis will be done in relation to pathology only.
  • Patients willing to participate as evidenced by signing the written informed consent.
  • Control subjects:
  • Subjects 18 years or over
  • Patients willing to participate as evidenced by signing the written informed consent

Exclusion

  • Ovarian cancer patients:
  • Subjects less than 18 years of age
  • Hematological malignancies
  • Previous ovarian tumor
  • Patients under active chemotherapy treatment
  • Patients not willing to sign written informed consent
  • Control subjects:
  • Subjects less than 18 years
  • Hematological malignancies
  • History of any past tumors
  • Other ovarian pathology
  • Patients who have been under anesthesia in the last 2 months
  • Patients treated with immunosuppressant drugs
  • Patients not willing to sign written informed consent

Key Trial Info

Start Date :

July 1 2006

Trial Type :

OBSERVATIONAL

End Date :

June 1 2008

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00327925

Start Date

July 1 2006

End Date

June 1 2008

Last Update

March 2 2007

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Shiba Hospital

Tel Litwinsky, Tel Aviv, Israel

2

Soroka

Beersheba, Israel

3

Carmel Hospital

Haifa, Israel

4

Hadassah Hospital, Ein Karem Campus

Jerusalem, Israel, 91120